Immunostep presents a renovated product line for basic and clinical research on exosomes

Exosomes are small (~40‐150 nm) extracellular vesicles (EVs) released from all cell types and found in body fluids and cell culture supernatants. In 2019 Immunostep R&D team recognized the great potential of these small extracellular vesicles and since then they have been working on the development of a line of products for research. 

Exosomes have been proposed to provide means for intercellular exchange and communication and that is the reason why the isolation and characterization of these exosomes from biological fluids can provide valuable information for early detection, disease monitoring and treatment development. 

Research on exosomes as a potential source of biomarkers of human disease has increased rapidly in recent years and consequently the need for new tools for the isolation and characterization of exosomes has also increased.

However, the use of exosomes in diagnostic tests or clinical research requires a sensitive, reproducible, and high-throughput method for the detection, characterization, and quantification of exosome samples. In this sense, Immunostep have been working to create an exosome innovative platform, backed by their extensive expertise in this area as an exosome reagent supplier worldwide. 

“At Immunostep, we will continue to work on amplify our technologies and transforming them into powerful tools that contribute and help exosome researchers worldwide.” 

Realising the tremendous opportunity that exosome isolation and characterization presents requires innovating to deliver highly accurate and reproducible methods. Immunostep makes available to its clients all their experience and technical capabilities in the field to make the use of these extracellular vesicles in different areas a reality.

(More info about this line: https://exosomes.immunostep.com)